http://classic.clinicaltrials.gov/ct2/show/NCT06000956?type=Intr&cond=ankylosing+spondylitis&phase=0124&lupd_s=08%2F07%2F2023&lupd_d=14&sort=nwst
STUDY TITLE:
A Study of Comparing Overall Improvement of Patients With Spondyloarthritis Treated With Jitongning Tablets and Placebo
DESCRIPTION:
Condition: Ankylosing Spondylitis
Interventions: Drug: Jitongning tablets; Drug: a simulated agent of Jitongning tablets
Sponsor: Tasly Pharmaceutical Group Co., Ltd
Recruiting
CLINICALTRIALS.GOV IDENTIFIER:
NCT06000956
FIRST POSTED:
Mon, 21 Aug 2023 12:00:00 EDT
LAST UPDATE POSTED:
08/21/23 09:23AM
STUDY LINK / URL:
http://classic.clinicaltrials.gov/ct2/show/NCT06000956?type=Intr&cond=ankylosing+spondylitis&phase=0124&lupd_s=08%2F07%2F2023&lupd_d=14&sort=nwst
